Related Experiment Videos
Myeloperoxidase and cardiovascular disease
Stephen J Nicholls1, Stanley L Hazen
1Department of Cardiovascular Medicine and Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Arteriosclerosis, Thrombosis, and Vascular Biology
|March 26, 2005
Summary
Myeloperoxidase (MPO) is an enzyme involved in inflammation and tissue damage. Targeting MPO and its pathways may help prevent cardiovascular disease progression.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Background:
- Myeloperoxidase (MPO) is an enzyme produced by leukocytes.
- MPO generates reactive oxidants, playing a role in innate immunity.
- MPO-derived oxidants are implicated in tissue damage during inflammation.
Purpose of the Study:
- To explore the role of MPO in cardiovascular disease.
- To identify MPO as a potential target for cardiovascular disease treatment.
Main Methods:
- This study reviews existing evidence on MPO's role in atherosclerosis.
- Analysis of MPO-catalyzed reactions and their impact on cardiovascular disease progression.
Main Results:
- MPO-catalyzed reactions contribute to proatherogenic activities.
- These activities span all phases of atherosclerosis, from initiation to complications.
Conclusions:
- MPO and its inflammatory pathways are key players in cardiovascular disease.
- MPO presents a promising target for cardiovascular disease prognostication and therapy.